AlphaQuest’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,991
Closed -$384K 606
2025
Q4
$384K Sell
24,991
-148,149
-86% -$1.63M 0.02% 1019
2025
Q3
$1.72M Buy
173,140
+90,641
+110% +$943K 0.11% 232
2025
Q2
$818K Buy
82,499
+27,579
+50% +$291K 0.08% 382
2025
Q1
$712K Buy
54,920
+31,483
+134% +$417K 0.08% 400
2024
Q4
$299K Buy
23,437
+2,172
+10% +$26.3K 0.04% 702
2024
Q3
$237K Buy
+21,265
New +$234K 0.02% 998
2024
Q2
Sell
-81
Closed -$1K 1659
2024
Q1
$1K Buy
+81
New +$1.06K ﹤0.01% 1415

Other funds holding DVAX

AlphaQuest's DVAX Position: Q1 2026 in Review

AlphaQuest sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 24,991 shares — an estimated $384K sold.

AlphaQuest first reported a position in DVAX in Q1 2024 and held it in 7 quarters. The position peaked at $1.72M in Q3 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • AlphaQuest reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 24,991 Dynavax Technologies shares in Q1 2026, an estimated $384K.
  • AlphaQuest first reported a position in Dynavax Technologies in Q1 2024 and held it in 7 quarters.
  • AlphaQuest's Dynavax Technologies position peaked at $1.72M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.